Delaware’s top court ruled in GSK’s favor in saying it will review the admissibility of expert evidence in an upcoming trial over possible cancer risks from its Zantac heartburn remedy
Add A Comment
GSK shares jump on win in Delaware court over ongoing Zantac battle
By